European Heart Journal Advance Access originally published online on September 19, 2006
European Heart Journal 2006 27(21):2573-2579; doi:10.1093/eurheartj/ehl207
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The relationship between coronary artery disease and abnormal glucose regulation in China: the China Heart Survey
1 Centre for Cardiovascular and Pulmonary Blood Vessels, Tongji University, Shanghai, China
2 Department of Endocrinology, General Hospital of the Chinese People's Liberation Army, Beijing, China
Received 25 April 2006; revised 8 August 2006; accepted 10 August 2006; online publish-ahead-of-print 19 September 2006.
* Corresponding author. Tel: +86 21 65981455; fax: +86 21 65981591. E-mail address: heart{at}gw-icc.org
See page 2491 for the editorial comment on this article (doi:10.1093/eurheartj/ehl300)
Aim The aim of this article is to characterize the glucometabolic state of patients with coronary artery disease (CAD) in China.
Methods and results This multicentre study recruited 3513 patients hospitalized for CAD, of whom 35.1% were admissions for acute CAD and 64.9% were elective admissions for CAD. At entry, 1153 patients had known type 2 diabetes and 97 had newly diagnosed diabetes [fasting plasma glucose level (FPG) 
7.0 mmol/L]. Oral glucose tolerance tests (OGTTs) performed in the remaining patients revealed that 26.9% had diabetes and 37.3% had impaired glucose regulation (IGR). The prevalence of abnormal glucose regulation (AGR) was similar in the acute and elective admissions groups. Overall, the proportion of patients with diagnosed diabetes increased from 32.8% at baseline to 52.9% post-OGTT analysis. In total, 87.4% of patients with IGR and 80.5% of patients with diabetes would have remained undiagnosed if OGTTs had not been performed.
Conclusion AGR is common in patients with CAD. The prevalence of AGR is underestimated by FPG testing alone. OGTTs should be routinely used to assess the glucometabolic state of patients with CAD. Individuals identified with IGR or type 2 diabetes should receive treatment to reduce the progression of AGR and associated complications.
Key Words: China Heart Survey • Coronary artery disease • Impaired glucose regulation • Oral glucose tolerance test • Type 2 diabetes
CiteULike 
Connotea 
Del.icio.us What's this?
Related articles in EHJ:
- Sweet and sour coronary heart disease: results from the China Heart Survey
- Veikko Salomaa
EHJ 2006 27: 2491-2492.[Extract] [FREE Full Text]
This article has been cited by other articles:
|
|
 |
|
  J. M. de la Hera, E. Delgado, E. Hernandez, J. M. Garcia-Ruiz, J. M. Vegas, P. Avanzas, I. Lozano, R. Barriales-Villa, S. Hevia, J. S. Martin, et al. Prevalence and outcome of newly detected diabetes in patients who undergo percutaneous coronary intervention Eur. Heart J., November 1, 2009; 30(21): 2614 - 2621. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Cosentino, L. Rydén, P. Francia, and L. G. Mellbin CHAPTER 14 Diabetes Mellitus and Metabolic Syndrome ESC Textbook of Cardiovascular Medicine, January 1, 2009; 2(1): med-9780199566990-chapter - med-9780199566990-chapter. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Anselmino, M. Wallander, A. Norhammar, L. Mellbin, and L. Ryden Implications of abnormal glucose metabolism in patients with coronary artery disease Diabetes and Vascular Disease Research, November 1, 2008; 5(4): 285 - 290. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden American College of Endocrinology Pre-Diabetes Consensus Conference: Part One Diabetes Care, October 1, 2008; 31(10): 2062 - 2069. [Full Text] [PDF]
|
|
|
|
|
|
M. Wallander, K. Malmberg, A. Norhammar, L. Ryden, and A. Tenerz Oral Glucose Tolerance Test: A Reliable Tool for Early Detection of Glucose Abnormalities in Patients With Acute Myocardial Infarction in Clinical Practice: A report on repeated oral glucose tolerance tests from the GAMI Study Diabetes Care, January 1, 2008; 31(1): 36 - 38. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Wallander, A. Norhammar, K. Malmberg, J. Ohrvik, L. Ryden, and K. Brismar IGF Binding Protein 1 Predicts Cardiovascular Morbidity and Mortality in Patients With Acute Myocardial Infarction and Type 2 Diabetes Diabetes Care, September 1, 2007; 30(9): 2343 - 2348. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. Salomaa Sweet and sour coronary heart disease: results from the China Heart Survey Eur. Heart J., November 1, 2006; 27(21): 2491 - 2492. [Full Text] [PDF]
|
|